Comet Bio Denmark ApS - CVR: 43297333

2023, DKK

12.07.2024

Bruttoresultat

-50.707'

Primær drift

-63.567'

Årets resultat

-65.765'

Aktiver

39.340'

Kortfristede aktiver

39.340'

Egenkapital

-69.758'

Afkastningsgrad

-162 %

Soliditetsgrad

-177 %

Likviditetsgrad

201 %

Resultat

12.07.2024

Årsrapport	2023 12.07.2024	2022 02.08.2023
Nettoomsætning
Bruttoresultat	-50.706.731	-5.043.974
Resultat af primær drift	-63.566.942	-5.405.830
Indtægter af kapitalandele (tilknyttede og associerede)	0	0
Finansielle indtægter	560.807	1.372.846
Finansieringsomkostninger	0	0
Andre finansielle omkostninger	-2.983.411	0
Resultat før skat	-65.989.546	-4.032.984
Resultat	-65.764.641	-4.032.984
Forslag til udbytte	0	0

Aktiver

12.07.2024

Årsrapport	2023 12.07.2024	2022 02.08.2023
Kortfristede varebeholdninger	0	419.351
Kortfristede tilgodehavender fra salg og tjenesteydelser	28.162.813	2.050.711
Likvider	11.176.725	0
Kortfristede aktiver	39.339.538	2.470.062
Immaterielle aktiver og goodwill	0	0
Finansielle anlægsaktiver	0	0
Materielle aktiver	0	918.010
Langfristede aktiver	0	918.010
Aktiver	39.339.538	3.388.072

Aktiver

12.07.2024

Passiver

12.07.2024

Årsrapport	2023 12.07.2024	2022 02.08.2023
Forslag til udbytte	0	0
Egenkapital	-69.757.625	-3.992.984
Hensatte forpligtelser	0	0
Langfristet gæld til banker	89.478.600	0
Leverandører af varer og tjenesteydelser	17.099.248	2.325.949
Kortfristede forpligtelser	19.618.563	7.381.056
Gældsforpligtelser	109.097.163	7.381.056
Forpligtelser	109.097.163	7.381.056
Passiver	39.339.538	3.388.072

Passiver

12.07.2024

Nøgletal

12.07.2024

Årsrapport	2023 12.07.2024	2022 02.08.2023
Afkastningsgrad	-161,6 %	-159,6 %
Dækningsgrad	Na.	Na.
Resultatgrad	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.
Egenkapitals-forretning	94,3 %	101,0 %
Payout-ratio	Na.	Na.
Gældsdæknings-nøgletal	Na.	Na.
Soliditestgrad	-177,3 %	-117,9 %
Likviditetsgrad	200,5 %	33,5 %

Resultat

12.07.2024

Gæld

12.07.2024

Årsrapport

12.07.2024

Nyeste:01.01.2023- 31.12.2023(offentliggjort: 12.07.2024)

Information om virksomhedens regnskabsklasse:The annual report of Comet Bio Denmark ApS for 2022 has been presented in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B with addition of a few provisions for reporting class C.

Oplysning om eventualaktiver:9. Contingent assets The Company has a deferred tax asset of DKK 12,435,000, which has not been recognised in the balance sheet. The tax asset can be attributed to tax losses carried forward which are not expected to be utilised within the next 3-5 years. The tax asset can be carried forward indefinitely.

Beretning

12.07.2024

Ledelsespåtegning: Today, Management has considered and adopted the Annual Report of Comet Bio Denmark ApS for the financial year 1 January 2023 - 31 December 2023. The Annual Report, which has not been audited, is presented in accordance with the Danish Financial Statements Act. Management believes that the financial statements give a true and fair view of the company's assets, liabilities and financial position and of the result. In our opinion, the Management's Review includes a true and fair account of the matters addressed in the review. The conditions for not conducting an audit of the Financial Statement have been met. The annual report is submitted for approval by the General Assembly. Kalundborg, 30 June 2024 Management Loula Sassaris Merkel

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today, Management has considered and adopted the Annual Report of Comet Bio Denmark ApS for the financial year 1 January 2023 - 31 December 2023.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:The Company's principal activities The Company's principal activities are to operate a business with manufacturing and/or distribution of food ingredients for sustainable products, as well as related business.